Please click here to see the latest news stories relating to Covid-19

Bionow members are welcome to submit PR items to this newsroom for all to see. Describing current activity and progress in the sector, it's a great place to promote your orgnaisation and keep up to date with the latest developments.

Whether currently a member or not, also keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Peak Proteins is a contract research organisation providing protein production and structure determination services. We chat to CEO of Peak Proteins, Dr. Mark Abbott.

We were asked by Grey Wolf Therapeutics (in collaboration with Sygnature Discovery) to provide support for an endoplasmic reticulum aminopeptidase-1 (ERAP1) drug discovery program.

Join us in a tour of key new features of Flare V4, the latest release of our structure-based design solution, which includes significant improvements to Free Energy Perturbation (FEP), new a...

Peak Proteins welcomes Richard Mott who joins us as a Business Development Associate working with our Head of Scientific Business Development, Dr Hazel Weir.

Medicines Discovery Catapult, Retrogenix and Peak Proteins announce a collaboration to advance understanding of the cellular mechanisms of infection by COVID-19.

There are challenges of working with a specific sub-type of membrane proteins called G-protein coupled receptors (GPCRs) however, it doesn’t have to be a labour-intensive process at all.

Dr Tomas Adomavicius joins Peak Proteins as a Protein Purification Expert. Tomas graduated from Vilnius University in Lithuania before coming to the UK to continue his studies.

Peak Proteins main priorities are always the health and well-being of our staff and their families. We are working hard to continue to deliver our services within government guidelines.

How druggable is your protein pocket?

Antimicrobial resistance is increasingly becoming one of the biggest challenges in modern life, and as an evolutionary process we must endeavour to pre-empt future resistance. By looking to...

Peak Proteins is now in a position where, in collaboration with the University of Leeds, we would be able to talk about cryo-EM approaches with clients having entered into an agreement with ...

By the time we are 65, one in ten of us will have contracted Alzheimer’s disease. Currently there are only four FDA approved drugs for the alleviation of the symptoms of Alzheimer’s dise...

Our Valued Sponsors & Partners